Temat: "Carcinoma, Endometrioid" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Genetically identification of endometriosis and cancers risk in women through a two-sample Mendelian randomization study.
Autorzy:: Zhang L; Department of Reproductive Medicine, The First Affiliated Hospital of Ningbo University (Ningbo First Hospital), Ningbo University, Ningbo, 315000, Zhejiang, People's Republic of China.
Yan H; Department of Urology, Ningbo Medical Center Lihuili Hospital, Ningbo University, Ningbo, 315000, Zhejiang, People's Republic of China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Apr 10; Vol. 14 (1), pp. 8382. Date of Electronic Publication: 2024 Apr 10.
Typ publikacji:: Journal Article
MeSH Terms:: Endometriosis*/genetics
Ovarian Neoplasms*/epidemiology
Ovarian Neoplasms*/genetics
Carcinoma, Endometrioid*
Female ; Humans ; Genome-Wide Association Study ; Mendelian Randomization Analysis ; Carcinoma, Ovarian Epithelial

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Accuracy of endometrial sampling in the diagnosis of endometrial cancer: a multicenter retrospective analysis of the JAGO-NOGGO.
Autorzy:: Alwafai Z; Department of Gynecology and Obstetrics, University of Greifswald, Greifswald, Germany.; Young Academy of Gynecologic Oncology (JAGO), Berlin, Germany.
Beck MH; Young Academy of Gynecologic Oncology (JAGO), Berlin, Germany. .; Department of Gynecology With Center for Oncological Surgery, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, Charité Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany. .; Department of Gynecology With Breast Center, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, Charité Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany. .
Fazeli S; Young Academy of Gynecologic Oncology (JAGO), Berlin, Germany.; Klinik Für Gynäkologie, Krankenhaus Waldfriede, Berlin, Germany.
Gürtler K; Young Academy of Gynecologic Oncology (JAGO), Berlin, Germany.; Klinik Für Gynäkologie, DRK-Kliniken Berlin Westend, Berlin, Germany.
Kunz C; Young Academy of Gynecologic Oncology (JAGO), Berlin, Germany.; Department of Gynecology and Obstetrics, Krankenhaus St. Elisabeth Und Barbara, Halle, Germany.
Singhartinger J; Young Academy of Gynecologic Oncology (JAGO), Berlin, Germany.; Department of Gynecology and Obstetrics, Klinikum Traunstein, Traunstein, Germany.
Trojnarska D; Young Academy of Gynecologic Oncology (JAGO), Berlin, Germany.; Faculty of Health Sciences, Jagiellonian University Medical College, Cracow, Poland.
Zocholl D; Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, corporate member of, Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
Krankenberg DJ; Department of Gynecology With Breast Center, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, Charité Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany.
Blohmer JU; Department of Gynecology With Breast Center, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, Charité Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany.
Sehouli J; Young Academy of Gynecologic Oncology (JAGO), Berlin, Germany.; Department of Gynecology With Center for Oncological Surgery, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, Charité Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.
Pietzner K; Young Academy of Gynecologic Oncology (JAGO), Berlin, Germany.; Department of Gynecology With Center for Oncological Surgery, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, Charité Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Mar 25; Vol. 24 (1), pp. 380. Date of Electronic Publication: 2024 Mar 25.
Typ publikacji:: Multicenter Study; Journal Article
MeSH Terms:: Endometrial Neoplasms*/diagnosis
Endometrial Neoplasms*/surgery
Endometrial Neoplasms*/pathology
Carcinoma*/pathology
Carcinoma, Endometrioid*/pathology
Female ; Humans ; Retrospective Studies ; Hysterectomy ; Endometrium/surgery ; Endometrium/pathology ; Neoplasm Grading ; Neoplasm Staging

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Association of tet methylcytosine dioxygenase 2 and 5-hydroxymethylcytosine in endometrioid adenocarcinoma and its clinical significance.
Autorzy:: Kuang L; Department of Obstetrics and Gynecology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, No. 199 South Jiefang Road, Xuzhou, 221009, China.
Zhang J; Department of Obstetrics and Gynecology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, No. 199 South Jiefang Road, Xuzhou, 221009, China.
Li Y; Department of Obstetrics and Gynecology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, No. 199 South Jiefang Road, Xuzhou, 221009, China.
Wang Q; Department of Obstetrics and Gynecology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, No. 199 South Jiefang Road, Xuzhou, 221009, China.
Liu J; Department of Obstetrics and Gynecology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, No. 199 South Jiefang Road, Xuzhou, 221009, China.
Zhang B; Department of Obstetrics and Gynecology, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, No. 199 South Jiefang Road, Xuzhou, 221009, China. .; Pokaż więcej
Źródło:: BMC women's health [BMC Womens Health] 2024 Mar 21; Vol. 24 (1), pp. 188. Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:: Journal Article
MeSH Terms:: 5-Methylcytosine*/analogs & derivatives
Carcinoma, Endometrioid*/genetics
Dioxygenases*/genetics
Dioxygenases*/metabolism
Endometrial Neoplasms*
Female ; Humans ; Clinical Relevance ; DNA Methylation ; DNA-Binding Proteins

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: The causal effects of genetically predicted alcohol consumption on endometrial cancer risk from a Mendelian randomization study.
Autorzy:: Yang J; Department of Oncology, Baoji Gaoxin Hospital, No.19, Gaoxin 4 Road, Gaoxin District, Baoji, 721000, Shaanxi Province, China.
Qu X; Department of Oncology, Baoji Gaoxin Hospital, No.19, Gaoxin 4 Road, Gaoxin District, Baoji, 721000, Shaanxi Province, China.
Zheng AJ; Department of Oncology, Baoji Gaoxin Hospital, No.19, Gaoxin 4 Road, Gaoxin District, Baoji, 721000, Shaanxi Province, China.
Jiang F; Department of Oncology, Baoji Gaoxin Hospital, No.19, Gaoxin 4 Road, Gaoxin District, Baoji, 721000, Shaanxi Province, China.
Chang H; Department of Oncology, Baoji Gaoxin Hospital, No.19, Gaoxin 4 Road, Gaoxin District, Baoji, 721000, Shaanxi Province, China.
Zhang JR; Department of Oncology, Baoji Gaoxin Hospital, No.19, Gaoxin 4 Road, Gaoxin District, Baoji, 721000, Shaanxi Province, China.
Yan LJ; Department of Oncology, Baoji Gaoxin Hospital, No.19, Gaoxin 4 Road, Gaoxin District, Baoji, 721000, Shaanxi Province, China.
Ning P; Department of Oncology, Baoji Gaoxin Hospital, No.19, Gaoxin 4 Road, Gaoxin District, Baoji, 721000, Shaanxi Province, China. ningpeng_.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 12; Vol. 14 (1), pp. 3478. Date of Electronic Publication: 2024 Feb 12.
Typ publikacji:: Journal Article
MeSH Terms:: Endometrial Neoplasms*/etiology
Endometrial Neoplasms*/genetics
Carcinoma, Endometrioid*
Female ; Humans ; Genome-Wide Association Study ; Mendelian Randomization Analysis ; Reproducibility of Results ; Alcohol Drinking/adverse effects ; Ethanol ; Chorionic Gonadotropin

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Expressions of HuR, Methyl-HuR and Phospho-HuR in Endometrial Endometrioid Adenocarcinoma Are Associated with Clinical Features.
Autorzy:: Hotton J; Department of Gynecology and Obstetrics, CHRU de Nancy, Université de Lorraine, 54000 Nancy, France.; INSERM U1256 NGERE, Université de Lorraine, 54500 Vandœuvre-lès-Nancy, France.
Gauchotte G; INSERM U1256 NGERE, Université de Lorraine, 54500 Vandœuvre-lès-Nancy, France.; Department of Biopathology CHRU of Nancy, Institut de Cancérologie de Lorraine, BBB, CHRU de Nancy, Université de Lorraine, 54511 Vandœuvre-lès-Nancy, France.; Centre de Ressources Biologiques, BB-0033-00035, CHRU de Nancy, 54000 Nancy, France.
Mougel R; INSERM U1256 NGERE, Université de Lorraine, 54500 Vandœuvre-lès-Nancy, France.; Department of Reproductive Medicine, CHRU de Nancy, Université de Lorraine, 54000 Nancy, France.
Migliorini M; INSERM U1256 NGERE, Université de Lorraine, 54500 Vandœuvre-lès-Nancy, France.
Lacomme S; Centre de Ressources Biologiques, BB-0033-00035, CHRU de Nancy, 54000 Nancy, France.
Battaglia-Hsu SF; INSERM U1256 NGERE, Université de Lorraine, 54500 Vandœuvre-lès-Nancy, France.
Agopiantz M; INSERM U1256 NGERE, Université de Lorraine, 54500 Vandœuvre-lès-Nancy, France.; Department of Reproductive Medicine, CHRU de Nancy, Université de Lorraine, 54000 Nancy, France.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Jan 12; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 12.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Endometrioid*/genetics
Carcinoma, Endometrioid*/metabolism
Endometrial Neoplasms*/genetics
Endometrial Neoplasms*/metabolism
ELAV-Like Protein 1*/genetics
ELAV-Like Protein 1*/metabolism
Female ; Humans ; Cell Proliferation ; Cytoplasm ; Cytosol

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Endometrioid carcinomas with sex cord-like formations and hyalinization: spontaneous pregnancy after conservative treatment.
Autorzy:: Gama Q; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, 128 Shenyang Road, Yangpu District, Shanghai, 200090, P.R. China.; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, 200090, China.
Luo S; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, 128 Shenyang Road, Yangpu District, Shanghai, 200090, P.R. China.; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, 200090, China.
Wu P; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, 128 Shenyang Road, Yangpu District, Shanghai, 200090, P.R. China.; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, 200090, China.
Wang L; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, 128 Shenyang Road, Yangpu District, Shanghai, 200090, P.R. China.; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, 200090, China.
Liu S; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, 128 Shenyang Road, Yangpu District, Shanghai, 200090, P.R. China.; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, 200090, China.
Zhang H; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, 200090, China.; Department of Cervix, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200090, China.
Sun L; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, 200090, China.; Department of Ultrasound, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200090, China.
Wang Y; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, 200090, China.; Department of Pathology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200090, China.
Yu M; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, 200090, China.; Department of Assisted Reproduction, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200090, China.
Chen X; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, 128 Shenyang Road, Yangpu District, Shanghai, 200090, P.R. China. .; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, 200090, China. .
Shan W; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, 128 Shenyang Road, Yangpu District, Shanghai, 200090, P.R. China. .; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, 200090, China. .
Luo X; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, 128 Shenyang Road, Yangpu District, Shanghai, 200090, P.R. China. .; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, 200090, China. .; Pokaż więcej
Źródło:: BMC pregnancy and childbirth [BMC Pregnancy Childbirth] 2024 Jan 04; Vol. 24 (1), pp. 30. Date of Electronic Publication: 2024 Jan 04.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Endometrioid*/pathology
Carcinoma, Endometrioid*/surgery
Endometrial Neoplasms*/pathology
Pregnancy ; Infant, Newborn ; Female ; Humans ; Male ; Young Adult ; Adult ; Conservative Treatment ; Uterus/pathology ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Assessment of endometrial carcinoma on biopsy as a predictor of final surgical pathology: Are we doing it right? A completed audit cycle and recommendations.
Autorzy:: Jassar A; Department of Cellular Pathology, University Hospital of North Durham, Durham, United Kingdom.
Hemali N; Department of Cellular Pathology, New Cross Hospital, Wolverhampton, United Kingdom.
Bhatnagar A; Department of Cellular Pathology, New Cross Hospital, Wolverhampton, United Kingdom.; Pokaż więcej
Źródło:: Indian journal of pathology & microbiology [Indian J Pathol Microbiol] 2024 Jan-Mar; Vol. 67 (1), pp. 68-73.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Endometrioid*/diagnosis
Carcinoma, Endometrioid*/surgery
Carcinoma, Endometrioid*/pathology
Endometrial Neoplasms*/diagnosis
Endometrial Neoplasms*/surgery
Endometrial Neoplasms*/pathology
Female ; Humans ; Neoplasm Grading ; Endometrium/pathology ; Biopsy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: To study the expression of estrogen, progesterone receptor and p53 immunohistochemistry markers in subtyping endometrial carcinoma.
Autorzy:: Yadav A; Department of Pathology, Apollo Hospitals, Jubilee Hills, Hyderabad, Andhra Pradesh, India.
Sistla A; Department of Pathology, Apollo Hospitals, Jubilee Hills, Hyderabad, Andhra Pradesh, India.
Swain M; Department of Pathology, Apollo Hospitals, Jubilee Hills, Hyderabad, Andhra Pradesh, India.
Gowrishankar S; Department of Pathology, Apollo Hospitals, Jubilee Hills, Hyderabad, Andhra Pradesh, India.
Padua M; Department of Pathology, Apollo Hospitals, Jubilee Hills, Hyderabad, Andhra Pradesh, India.
Modi T; Department of Pathology, Apollo Hospitals, Jubilee Hills, Hyderabad, Andhra Pradesh, India.
Himabindu R; Department of Pathology, Apollo Hospitals, Jubilee Hills, Hyderabad, Andhra Pradesh, India.
Agarwal N; Department of Pathology, Apollo Hospitals, Jubilee Hills, Hyderabad, Andhra Pradesh, India.
Kulkarni A; Department of Pathology, Apollo Hospitals, Jubilee Hills, Hyderabad, Andhra Pradesh, India.
Bhandari T; Department of Surgical Oncology, Apollo Hospitals, Jubilee Hills, Hyderabad, Andhra Pradesh, India.
Vudayaraju H; Department of Surgical Oncology, Apollo Hospitals, Jubilee Hills, Hyderabad, Andhra Pradesh, India.
Chinnababu; Department of Surgical Oncology, Apollo Hospitals, Jubilee Hills, Hyderabad, Andhra Pradesh, India.
Reddy VA; Department of Surgical Oncology, Apollo Hospitals, Jubilee Hills, Hyderabad, Andhra Pradesh, India.; Pokaż więcej
Źródło:: Indian journal of pathology & microbiology [Indian J Pathol Microbiol] 2024 Jan-Mar; Vol. 67 (1), pp. 62-67.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Endometrioid*/diagnosis
Carcinoma, Endometrioid*/pathology
Endometrial Neoplasms*/diagnosis
Endometrial Neoplasms*/pathology
Female ; Humans ; Immunohistochemistry ; Tumor Suppressor Protein p53/metabolism ; Receptors, Progesterone/metabolism ; Estrogens ; Receptors, Estrogen/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: ARID1A loss activates MAPK signaling via DUSP4 downregulation.
Autorzy:: Mandal J; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Yu ZC; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Shih IM; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. .; Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA. .; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA. .
Wang TL; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. .; Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA. .; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA. .; Pokaż więcej
Źródło:: Journal of biomedical science [J Biomed Sci] 2023 Dec 09; Vol. 30 (1), pp. 94. Date of Electronic Publication: 2023 Dec 09.
Typ publikacji:: Journal Article
MeSH Terms:: Nuclear Proteins*/genetics
Carcinoma, Endometrioid*/genetics
Carcinoma, Endometrioid*/metabolism
Carcinoma, Endometrioid*/pathology
Female ; Humans ; Mice ; Animals ; Down-Regulation ; Mitogen-Activated Protein Kinase Phosphatases/genetics ; Mitogen-Activated Protein Kinase Phosphatases/metabolism ; Dual-Specificity Phosphatases/genetics ; Dual-Specificity Phosphatases/metabolism ; DNA-Binding Proteins/genetics ; DNA-Binding Proteins/metabolism ; Transcription Factors/genetics ; Transcription Factors/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Dedifferentiated Ovarian Carcinoma with ARID1A and ARID1B Mutations: A Clinicopathological Report and Literature Review.
Autorzy:: Kamal M; Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Atwi D; Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Pang H; Genetics Lab, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Li S; Genetics Lab, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Hassell L; Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.; Pokaż więcej
Źródło:: International journal of surgical pathology [Int J Surg Pathol] 2023 Dec; Vol. 31 (8), pp. 1526-1531. Date of Electronic Publication: 2023 Feb 27.
Typ publikacji:: Review; Case Reports; Journal Article
MeSH Terms:: Endometrial Neoplasms*/genetics
Endometrial Neoplasms*/pathology
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/pathology
Carcinoma, Endometrioid*/genetics
Carcinoma, Endometrioid*/pathology
Female ; Humans ; Aged ; Carcinoma, Ovarian Epithelial ; Mutation ; Biomarkers, Tumor ; DNA-Binding Proteins/genetics ; Transcription Factors/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma.
Autorzy:: Wang G; Department of Dalian Key Laboratory of Reproduction and Mother-child Genetic, Reproductive & Genetic Medicine Center, Dalian Women and Children's Medical Group, Dalian, Liaoning Province, China.
Fu J; Department of Obstetrics and Gynecology, the First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, China.
Liu M; Department of Clinical Laboratory, the First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, China.
Zheng Q; Department of Biochemistry and Molecular Biology, Dalian Medical University, Dalian, Liaoning Province, China.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Jan 17; Vol. 19 (1), pp. e0277872. Date of Electronic Publication: 2024 Jan 17 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Endometrioid*
Endometrial Neoplasms*/genetics
Female ; Humans ; Biomarkers ; DNA Methylation ; Databases, Factual ; Immunotherapy ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Analysis of long non-coding RNAs associated with disulfidptosis for prognostic signature and immunotherapy response in uterine corpus endometrial carcinoma.
Autorzy:: Li B; Department of Gynecology and Oncology, Inner Mongolia Medical University, Affiliated Cancer Hospital, 42 Zhaowuda Road, Saihan District, Hohhot, 010000, Inner Mongolia, China.
Li X; Department of General Surgery, Inner Mongolia Medical University, Affiliated Cancer Hospital, 42 Zhaowuda Road, Saihan District, Hohhot, 010000, Inner Mongolia, China.
Ma M; Department of Gynecology and Oncology, Inner Mongolia Medical University, Affiliated Cancer Hospital, 42 Zhaowuda Road, Saihan District, Hohhot, 010000, Inner Mongolia, China.
Wang Q; Department of Gynaecology and Obstetrics, Xi'an No. 3 Hospital, The Affiliated Hospital of Northwest University, No. 10, East Section of Fengcheng Third Road, Weiyang District, Xi'an, 710018, Shaanxi, China.
Shi J; Department of Gynecology and Oncology, Inner Mongolia Medical University, Affiliated Cancer Hospital, 42 Zhaowuda Road, Saihan District, Hohhot, 010000, Inner Mongolia, China. .
Wu C; Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Huanhu West Road, Hexi District, Tianjin, 300060, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Dec 14; Vol. 13 (1), pp. 22220. Date of Electronic Publication: 2023 Dec 14.
Typ publikacji:: Randomized Controlled Trial; Journal Article
MeSH Terms:: RNA, Long Noncoding*/genetics
Carcinoma, Endometrioid*
Humans ; Female ; Prognosis ; Immunotherapy ; Disulfides ; Tumor Microenvironment/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: The pregnancy and oncology outcome of fertility-sparing management for synchronous primary neoplasm of endometrium and ovary.
Autorzy:: Gama Q; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, 128 Shenyang Road, Yangpu District, Shanghai, 200090, P.R. China.; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, 200090, China.
Luo S; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, 128 Shenyang Road, Yangpu District, Shanghai, 200090, P.R. China.; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, 200090, China.
Wu P; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, 128 Shenyang Road, Yangpu District, Shanghai, 200090, P.R. China.; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, 200090, China.
Wang L; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, 128 Shenyang Road, Yangpu District, Shanghai, 200090, P.R. China.; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, 200090, China.
Liu S; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, 128 Shenyang Road, Yangpu District, Shanghai, 200090, P.R. China.; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, 200090, China.
Zhang H; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, 200090, China.; Department of Cervix, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200090, China.
Sun L; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, 200090, China.; Department of Ultrasound, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200090, China.
Wang Y; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, 200090, China.; Department of Pathology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200090, China.
Yu M; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, 200090, China.; Department of Assisted Reproduction, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200090, China.
Chen X; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, 128 Shenyang Road, Yangpu District, Shanghai, 200090, P.R. China. .; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, 200090, China. .
Shan W; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, 128 Shenyang Road, Yangpu District, Shanghai, 200090, P.R. China. .; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, 200090, China. .
Luo X; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, 128 Shenyang Road, Yangpu District, Shanghai, 200090, P.R. China. .; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, 200090, China. .; Pokaż więcej
Źródło:: Journal of ovarian research [J Ovarian Res] 2023 Dec 08; Vol. 16 (1), pp. 235. Date of Electronic Publication: 2023 Dec 08.
Typ publikacji:: Journal Article
MeSH Terms:: Endometrial Neoplasms*/pathology
Fertility Preservation*
Endometrial Hyperplasia*/drug therapy
Endometrial Hyperplasia*/pathology
Carcinoma, Endometrioid*/pathology
Neoplasms, Multiple Primary*/therapy
Neoplasms, Multiple Primary*/pathology
Pregnancy ; Female ; Humans ; Adult ; Retrospective Studies ; Treatment Outcome ; Neoplasm Recurrence, Local/pathology ; Endometrium/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Deciphering tumor immune microenvironment differences between high-grade serous and endometrioid ovarian cancer to investigate their potential in indicating immunotherapy response.
Autorzy:: Yang H; Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, National Clinical Research Center for Obstetric & Gynecologic Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuai Fu Yuan, Wang Fu Jing Street, Beijing, China.
Gu X; Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, National Clinical Research Center for Obstetric & Gynecologic Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuai Fu Yuan, Wang Fu Jing Street, Beijing, China.; 4+4 Medical Doctor Program, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Fan R; Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, National Clinical Research Center for Obstetric & Gynecologic Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuai Fu Yuan, Wang Fu Jing Street, Beijing, China.
Zhu Q; Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, National Clinical Research Center for Obstetric & Gynecologic Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuai Fu Yuan, Wang Fu Jing Street, Beijing, China.; Department of Obstetrics and Gynecology, Beijing Puren Hospital, Beijing, China.
Zhong S; Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, National Clinical Research Center for Obstetric & Gynecologic Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuai Fu Yuan, Wang Fu Jing Street, Beijing, China.
Wan X; Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, National Clinical Research Center for Obstetric & Gynecologic Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuai Fu Yuan, Wang Fu Jing Street, Beijing, China.
Chen Q; Thorgene Co., Ltd, Beijing, China.
Zhu L; Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, National Clinical Research Center for Obstetric & Gynecologic Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuai Fu Yuan, Wang Fu Jing Street, Beijing, China. zhu_.
Feng F; Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, National Clinical Research Center for Obstetric & Gynecologic Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuai Fu Yuan, Wang Fu Jing Street, Beijing, China. .; Pokaż więcej
Źródło:: Journal of ovarian research [J Ovarian Res] 2023 Nov 22; Vol. 16 (1), pp. 223. Date of Electronic Publication: 2023 Nov 22.
Typ publikacji:: Journal Article
MeSH Terms:: Ovarian Neoplasms*/genetics
Carcinoma, Endometrioid*/therapy
Cystadenocarcinoma, Serous*/pathology
Humans ; Female ; Carcinoma, Ovarian Epithelial/pathology ; Tumor Microenvironment ; Immunotherapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Effects of radiotherapy on the survival of patients with stage IA and low-grade stage IB uterine endometrioid carcinoma.
Autorzy:: Li S; Department of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital of Fudan University, 128 Shenyang Road, Shanghai, 200090, People's Republic of China.
Yi Z; Department of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital of Fudan University, 128 Shenyang Road, Shanghai, 200090, People's Republic of China.
Li M; Department of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital of Fudan University, 128 Shenyang Road, Shanghai, 200090, People's Republic of China.
Zhu Z; Department of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital of Fudan University, 128 Shenyang Road, Shanghai, 200090, People's Republic of China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Nov 14; Vol. 13 (1), pp. 19883. Date of Electronic Publication: 2023 Nov 14.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Endometrioid*/pathology
Endometrial Neoplasms*/pathology
Female ; Humans ; Uterus/pathology ; Proportional Hazards Models ; Radiotherapy, Adjuvant ; Neoplasm Staging ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: The effect of cuproptosis-relevant genes on the immune infiltration and metabolism of gynecological oncology by multiply analysis and experiments validation.
Autorzy:: Ran XM; Department of Gynecologic Oncology Ward5, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
Xiao H; Department of Gynecologic Oncology Ward1, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
Tang YX; Department of Gynecologic Oncology Ward1, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
Jin X; Department of Pathology, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
Tang X; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of the University of South China, Hengyang, Hunan, China.
Zhang J; Department of Assisted Reproductive Centre, Zhuzhou Central Hospital, Xiangya Hospital, Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China.
Li H; Department of Assisted Reproductive Centre, Zhuzhou Central Hospital, Xiangya Hospital, Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China.
Li YK; Department of Assisted Reproductive Centre, Zhuzhou Central Hospital, Xiangya Hospital, Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China.
Tang ZZ; Department of Gynecologic Oncology Ward1, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China. Tangzhenzi_.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Nov 09; Vol. 13 (1), pp. 19474. Date of Electronic Publication: 2023 Nov 09.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Endometrioid*
Carcinoma, Squamous Cell*
Ovarian Neoplasms*/genetics
Uterine Cervical Neoplasms*/genetics
Apoptosis*
Animals ; Female ; Humans ; Biological Assay ; Disease Models, Animal ; Tumor Microenvironment/genetics ; Copper

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Pancancer analysis of the correlations of HS6ST2 with prognosis, tumor immunity, and drug resistance.
Autorzy:: Chen W; Medical School of Nantong University, Nantong, 226007, China.; Department of Oncology, Affiliated Hospital of Nantong University, Nantong, 226001, China.; Department of Radiotherapy, The Sixth Affiliated Hospital of Nantong University, Yancheng Third People's Hospital, The Yancheng School of Clinical Medicine of Nanjing Medical University, Yancheng, 224002, China.
Li X; Department of General Medicine, The Sixth Affiliated Hospital of Nantong University, Yancheng Third People's Hospital, The Yancheng School of Clinical Medicine of Nanjing Medical University, Yancheng, 224002, China.
Jiang Y; Department of Radiotherapy, The Sixth Affiliated Hospital of Nantong University, Yancheng Third People's Hospital, The Yancheng School of Clinical Medicine of Nanjing Medical University, Yancheng, 224002, China.
Ni D; Department of Radiotherapy, The Sixth Affiliated Hospital of Nantong University, Yancheng Third People's Hospital, The Yancheng School of Clinical Medicine of Nanjing Medical University, Yancheng, 224002, China.
Yang L; Medical School of Nantong University, Nantong, 226007, China.
Wu J; Department of Cardiothoracic Surgery, The Sixth Affiliated Hospital of Nantong University, Yancheng Third People's Hospital, The Yancheng School of Clinical Medicine of Nanjing Medical University, Yancheng, 224002, China.
Gao M; Department of Cardiothoracic Surgery, The Sixth Affiliated Hospital of Nantong University, Yancheng Third People's Hospital, The Yancheng School of Clinical Medicine of Nanjing Medical University, Yancheng, 224002, China.
Wang J; Department of Cardiothoracic Surgery, The Sixth Affiliated Hospital of Nantong University, Yancheng Third People's Hospital, The Yancheng School of Clinical Medicine of Nanjing Medical University, Yancheng, 224002, China. .
Song J; Department of Cardiothoracic Surgery, The Sixth Affiliated Hospital of Nantong University, Yancheng Third People's Hospital, The Yancheng School of Clinical Medicine of Nanjing Medical University, Yancheng, 224002, China. .
Shi W; Medical School of Nantong University, Nantong, 226007, China. .; Department of Oncology, Affiliated Hospital of Nantong University, Nantong, 226001, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Nov 06; Vol. 13 (1), pp. 19209. Date of Electronic Publication: 2023 Nov 06.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Carcinoma, Renal Cell*
Carcinoma, Endometrioid*
Kidney Neoplasms*
Lung Neoplasms*
Humans ; Female ; Carcinogenesis ; Prognosis ; Cell Transformation, Neoplastic ; Drug Resistance ; RNA ; Tumor Microenvironment ; Sulfotransferases

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: RNA modification regulator DDC in endometrial cancer affects the tumor microenvironment and patient prognosis.
Autorzy:: Zhao H; Shengjing Hospital of China Medical University, 110001, Shenyang, Liaoning, China.
Shi C; Guangming Community Health Service Center, 101127, Shunyi District, Beijing, China.
Zhao G; Shengjing Hospital of China Medical University, 110001, Shenyang, Liaoning, China.
Liu J; Zigong First People's Hospital, 643099, Zigong, Sichuan, China.
Wang X; The First Hospital of China Medical University, 110001, Shenyang, Liaoning, China.
Liang J; The First Hospital of China Medical University, 110001, Shenyang, Liaoning, China. .
Li F; The First Hospital of China Medical University, 110001, Shenyang, Liaoning, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Oct 23; Vol. 13 (1), pp. 18057. Date of Electronic Publication: 2023 Oct 23.
Typ publikacji:: Journal Article
MeSH Terms:: Endometrial Neoplasms*/genetics
Carcinoma, Endometrioid*
Humans ; Female ; Tumor Microenvironment/genetics ; Prognosis ; RNA ; Aromatic-L-Amino-Acid Decarboxylases

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: UBE2C serves as a prognosis biomarker of uterine corpus endometrial carcinoma via promoting tumor migration and invasion.
Autorzy:: Ma S; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, People's Republic of China.; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, People's Republic of China.; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, People's Republic of China.
Chen Q; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, People's Republic of China.
Li X; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, People's Republic of China.; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, People's Republic of China.; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, People's Republic of China.
Fu J; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, People's Republic of China. .; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, People's Republic of China. .; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, People's Republic of China. .
Zhao L; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, People's Republic of China.; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, People's Republic of China.; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, People's Republic of China.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Oct 06; Vol. 13 (1), pp. 16899. Date of Electronic Publication: 2023 Oct 06.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Endometrial Neoplasms*/genetics
Carcinoma, Endometrioid*
Female ; Humans ; Ubiquitin-Conjugating Enzymes/genetics ; Ubiquitin-Conjugating Enzymes/metabolism ; Neoplastic Processes ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Is HOXA5 a Novel Prognostic Biomarker for Uterine Corpus Endometrioid Adenocarcinoma?
Autorzy:: Song C; Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan 44033, Republic of Korea.
Kim KB; Department of Laboratory Medicine, Keimyung University School of Medicine, Daegu 42601, Republic of Korea.
Lee GS; Department of Obstetrics and Gynecology, Keimyung University School of Medicine, Daegu 42601, Republic of Korea.
Shin S; Department of Pediatrics, Keimyung University School of Medicine, Daegu 42601, Republic of Korea.
Kim B; Department of Radiology, Keimyung University School of Medicine, Daegu 42601, Republic of Korea.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Sep 29; Vol. 24 (19). Date of Electronic Publication: 2023 Sep 29.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Endometrioid*/pathology
Endometrial Neoplasms*/metabolism
Female ; Humans ; Genes, Homeobox ; Prognosis ; Homeodomain Proteins/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Carcinoma, Endometrioid"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język